Department of Physical Medicine and Rehabilitation, Hospital Jean-Minjoz, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France.
Department of Rheumatology, Hôpital Nord Franche-Comté, Belfort, France.
Cartilage. 2023 Jun;14(2):136-143. doi: 10.1177/19476035221109230. Epub 2022 Dec 17.
Advanced radiological stage of knee osteoarthritis (OA) is predictive of poor response to viscosupplementation (VS). To date, the impact of x-ray features on the duration of effectiveness (DE) of VS has not been investigated.
To investigate the radiological features associated with DE of VS in patients with knee OA.
Cross-sectional study in patients with knee OA treated with 1 injection of cross-linked hyaluronic acid (HA). The primary outcome was DE, self-assessed by the patients in weeks of effectiveness. Radiological features (joint space narrowing-JSN topography and Kellgren-Lawrence [K-L] grade) associated with DE were studied.
Fifty-one patients-33 females (76 knees)-were analyzed. The average DE was 52.0 (24.7) weeks (range, 13-155 weeks). In the bivariate analysis, DE was 14 weeks longer in those with K-L grades 1 and 2 (62.6 ± 36.4 weeks) than in those with K-L 3 and 4 (48.9 ± 18.6) ( = 0.03). DE was not significantly different according to the involved compartment(s). It was significantly longer in men than in women (60 ± 31.4 vs. 47 ± 16 weeks; = 0.035). In multivariate analysis, K-L grade (1-2 vs. 3-4) ( = 0.007), male gender (0.02), and older age (0.04) were independently associated with a longer DE.
DE of a single injection of extended-release HA is longer in K-L 1-2 than in K-L 3-4 OA knees, regardless of the JSN topography. However, even the patients with more advanced OA benefited from HANOX-M-XL injection for an average duration barely less than 1 year.
膝关节骨关节炎(OA)的高级放射学分期可预测玻璃酸钠(VS)治疗反应不佳。迄今为止,尚未研究 X 射线特征对 VS 有效性持续时间(DE)的影响。
研究膝关节 OA 患者 VS 持续时间与放射学特征的关系。
对接受 1 次交联透明质酸(HA)治疗的膝关节 OA 患者进行横断面研究。主要结局为患者以周为单位评估的 DE。研究与 DE 相关的放射学特征(关节间隙狭窄-JSN 形态和 Kellgren-Lawrence [K-L] 分级)。
共分析了 51 例患者(33 名女性,76 膝)。平均 DE 为 52.0(24.7)周(范围,13-155 周)。在单变量分析中,K-L 分级 1 和 2 的患者 DE 长 14 周(62.6 ± 36.4 周),而 K-L 分级 3 和 4 的患者 DE 为 48.9 ± 18.6 周( = 0.03)。受累关节数对 DE 无显著影响。男性 DE 明显长于女性(60 ± 31.4 比 47 ± 16 周; = 0.035)。多变量分析表明,K-L 分级(1-2 比 3-4)( = 0.007)、男性(0.02)和年龄较大(0.04)与更长的 DE 独立相关。
与 K-L 3-4 OA 膝关节相比,K-L 1-2 膝关节单次注射长链 HA 的 DE 更长,与 JSN 形态无关。然而,即使是更晚期的 OA 患者也从 HANOX-M-XL 注射中受益,平均持续时间略短于 1 年。